Terrence A. Duffy

Chairman and CEO at CME GROUP

Board

Since November 2016

Age

66 years

Education

Has an academic background from the University of Wisconsin-Whitewater and earned honorary degrees including a Doctor of Public Service from Saint Xavier University in 2019 and a Doctor of Humane Letters from DePaul University in 2007.

Tenure

Began his association with CME in 1981 as a member, joined the board in 1995, and has served in key roles including Vice Chairman, Executive Chairman, Executive Chairman and President, and now as Chairman and CEO since November 2016.

Also at CME GROUP

BTD

Bryan T. Durkin

Board Member

Jonathan Marcus

Senior Managing Director and General Counsel

Julie Winkler

Chief Commercial Officer (CCO)

About

Terrence A. Duffy is a 66-year-old executive who has demonstrated long-term leadership at CME Group, beginning his journey as a member in 1981 before joining the board of directors in 1995.

Throughout his distinguished career at CME, he has held a series of progressively responsible roles—from serving as Vice Chairman to Executive Chairman and President, and ultimately assuming the role of Chairman and Chief Executive Officer in November 2016.

In addition to his leadership at CME, his strategic vision has steered significant milestones, including the pioneering demutualization and public listing of the exchange, orchestrating key mergers and acquisitions, and spearheading the landmark Google Cloud partnership in 2021. His contributions also extend to public service, exemplified by his tenure on the Federal Retirement Thrift Investment Board from 2003 to 2013.

$CME Performance Under Terrence A. Duffy

Past Roles

Organization	Role	Date Range	Details
CME Group	Executive Chairman and President	May 2012 - November 2016	Stepped down upon promotion to Chairman and CEO
CME Group	Executive Chairman	October 2006 - May 2012	N/A
CME Group / CME Holdings	Chairman of the Board	April 2002 - October 2006	Oversaw board responsibilities for both entities
CME Holdings	Vice Chairman of the Board	August 2001 - April 2002	N/A
CME Group	Vice Chairman of the Board	1998 - April 2002	N/A
TDA Trading, Inc.	President	1981 - 2002	Pre-CME experience

External Roles

Organization	Role	Date Range	Details
Mayo Clinic Greater Chicago Leadership Council	Co-Chair	N/A	N/A
CME Group Foundation	Vice Chairman	N/A	N/A
Economic Club of Chicago	Member	N/A	N/A
Executives' Club of Chicago	Member	N/A	N/A
Chicago Council on Global Affairs (President's Circle)	Member	N/A	N/A

Fixed Compensation

Data from FY 2023

Component Name	Amount	Payment Schedule	Additional Details
Base Salary	$2,000,000	Annual	Fixed annual salary for 2023.
401(k) Company Contribution	$9,900	Annual	Contribution to 401(k) plan.
Supplemental Plan Contributions (401(k) & Pension make-whole)	$899,764	Annual	For compensation exceeding statutory limits under Section 401(a)(17).
Other Compensation	$1,210	Annual	Includes life insurance premiums with no additional supplemental life and long-term disability payments incurred.

Performance Compensation

Data from FY 2023

Performance Shares – TSR

Metric	Details	Citation
Performance Metric	TSR relative to the S&P 500
Performance Period	2024-2026
Threshold Shares	7,253
Target Shares	14,505
Maximum Shares	29,010
Payout Conditions	Below 25th percentile: 0%; 25th percentile: 50%; 50th percentile: 100%; 75th percentile or above: 200% (capped at 100% if absolute TSR is negative)
Grant Date	September 15, 2023
Grant Date Fair Value	$3,427,096
Grant Date Stock Price	$236.27
Vesting Schedule	Vests in full after the three-year performance period (2024-2026)

Performance Shares – Net Income Margin (NIM)

Metric	Details	Citation
Performance Metric	Absolute Net Income Margin Performance
Performance Period	2024-2026
Threshold Shares	7,253
Target Shares	14,505
Maximum Shares	29,010
Payout Conditions	50% payout if at threshold, 100% if target met, 200% if maximum achieved
Grant Date	December 5, 2023
Grant Date Fair Value	$3,167,022
Grant Date Stock Price	$218.34
Vesting Schedule	Vests in full after the three-year performance period (2024-2026)

Annual Equity Awards Summary

Composition: 50% performance shares (as detailed above) and 50% time-vested restricted stock.
Restricted Stock Vesting: Vests ratably over a four-year period.
Evaluation Period: Performance for both TSR and NIM components is evaluated over 2024-2026.
Additional Conditions: Performance shares are subject to adjustments based on actual results; for TSR, if the company’s absolute TSR is negative the maximum payout is capped at the target level (100%).